Reported about 19 hours ago
Johnson & Johnson reported strong first quarter earnings with a revenue of $21.9 billion, surpassing Wall Street expectations. However, the CFO noted that tariff impacts from exports to China are significant, estimating around $400 million, predominantly affecting the medical devices sector. The company has raised its 2025 sales guidance, despite ongoing challenges including the investigation into pharmaceutical tariffs and legal issues related to talc litigation.
Source: YAHOO